Drug Profile
Montirelin
Alternative Names: CG 3703; CNK 602A; NS 3; RemnosLatest Information Update: 31 May 2001
Price :
$50
*
At a glance
- Originator Grunenthal
- Developer Grunenthal; Nippon Shinyaku
- Class Antidepressants; Antiepileptic drugs; Hormones; Neuroprotectants; Nootropics; Small molecules
- Mechanism of Action Thyrotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cognition disorders; Epilepsy
Most Recent Events
- 31 May 2001 Discontinued-II for Cognition disorders in Germany (Unknown route)
- 31 May 2001 Discontinued-preregistration for Cognition disorders in Japan (Unknown route)
- 31 May 2001 Discontinued-Unspecified phase in Epilepsy in Japan (Unknown route)